NEW YORK (Reuters) - Supplies of the blood-thinning drug heparin are being recalled in France, Italy and Denmark because they are contaminated or suspected of being contaminated, although there have been no reports of patients being harmed by the medicine in those countries, the Wall Street Journal said.
